Giorgio Speranza, FBK researcher, awarded the Veneto Nanotech Prize in memory of Giovanna Cadini

Giorgio Speranza nel laboratorio FBK

Giorgio Speranza, senior rsearcher with the PAM-SE group at the Center for materials and microsystems of the Trento based Fondazione Bruno Kessler, won the Veneto Nanotech Award in memory of Giovanna Cadini , a recognition for frontier research in the field of nano-medicine. 
The prize, financed by Veneto Nanotech, was awarded in Venice on Thursday, November 22, at the Nanotechitaly 2012 (International showcase for Nanotechologies).
Speranza's work, which ranked as the best poster contribution of the “Health Care” section, deals with the “In Vitro Investigation of Doxorubicin Release from Gold Nanoparticles Coated by Electrolyte Multilayer”, part of an international project funded by the Autonomous Province of Trento. The aim is to synthesize nano-vectors (smart material supports) for controlled release of drugs –  doxorubicine, in this case.

La targa di Veneto Nanotech come riconoscimento del premio

Explains Speranza: “We tested these innovative gold nanoparticle supports with a well known drug- commonly used in chemotherapy. The difference between the traditional administration into a vein and the one proposed by the research is that the drug remains sequestered inside the carrier until it reaches the tumor tissue. Cancer cells have specific receptors that can bind to specific antibodies. These are placed on the surface of the carrier and fit perfectly on tumor receptors  targeting in a precise manner the tumor cells. The technique entails, in the phase of use of the drug, minor contraindications and side effects on the patient and hopefully a greater effectiveness of therapy”.
Massimo Gentili, Director of the Center for Materials and microsystems at the Fondazione Bruno Kessler, stresses the significance of Speranza's research: “Our goal is to condusct applicated research, whose impact can be measured on industry and especially on society. This research– whose aim is to reduce the negative consequences of chemotherapy on patients– perfectly reflects such spirit, and abides by the guidelines of the  future 8th European  Reseaerch Framework Program which will be enforced in 2014; the latter provides that each project will always have a positive impact on the people and theor wellbeing”. (m.l.)
Date: 
Monday, 26 November, 2012